Botensilimab and Balstilimab Optimization in Colorectal Cancer (BBOpCo)
Latest Information Update: 26 Feb 2025
At a glance
- Drugs Balstilimab (Primary) ; Botensilimab (Primary) ; Bevacizumab; Fluorouracil; Folinic acid; Oxaliplatin; Panitumumab
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms BBOpCo
Most Recent Events
- 23 Feb 2025 According to an Agenus Inc media release, a Trial-in-Progress (TiP) poster data will be presented from this study at the upcoming American Association for Cancer Research (AACR) IO Annual Meeting that will take place on February 23-26 in Los Angeles, California.
- 20 Nov 2024 Status changed from not yet recruiting to recruiting.
- 19 Sep 2024 Planned initiation date changed from 1 Jul 2024 to 1 Oct 2024.